$69.8 K

SCIE Mkt cap, 01-Oct-2018
SpectraScience Net income (Q3, 2017)-1.5 M
SpectraScience EBIT (Q3, 2017)-396.5 K
SpectraScience Cash, 30-Sep-201727.9 K
SpectraScience EV154.9 K

SpectraScience Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

240.0k6.6k5.2k

Revenue growth, %

(22%)

Cost of goods sold

125.4k8.1k602.0199.4k

Gross profit

114.6k6.0k(194.3k)

Gross profit Margin, %

48%91%(3772%)

Sales and marketing expense

267.8k374.8k294.4k368.4k

R&D expense

644.1k924.4k719.2k636.6k

General and administrative expense

1.9m1.4m1.5m1.2m

Operating expense total

2.8m2.7m2.5m2.2m

EBIT

(2.7m)(2.7m)(2.5m)(2.4m)

EBIT margin, %

(1138%)(37627%)(47460%)

Interest expense

295.1k499.8k667.9k963.5k

Net Income

(2.7m)(4.5m)(3.6m)(4.5m)

Quarterly

USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017

Revenue

120.0k60.0k950.04.2k

Cost of goods sold

73.5k36.8k6.0k6.0k6.0k868.02.1k

Gross profit

46.5k23.2k(6.0k)82.02.1k

Gross profit Margin, %

39%39%9%50%

Sales and marketing expense

89.7k33.3k89.6k140.8k114.2k39.9k94.1k50.7k79.4k101.2k90.3k73.8k57.4k

R&D expense

193.5k59.2k258.2k276.2k138.8k174.7k157.3k172.4k194.0k194.2k127.4k128.7k117.6k

General and administrative expense

654.9k375.2k519.8k292.9k280.0k381.5k344.8k284.7k307.8k306.2k282.0k305.6k221.5k

Operating expense total

938.0k467.7k867.6k709.8k533.0k596.0k596.2k507.8k581.3k601.6k499.7k508.0k396.5k

Depreciation and amortization

119.5k

EBIT

(891.5k)(444.4k)(861.6k)(709.8k)(533.0k)(590.0k)(590.2k)(507.8k)(581.3k)(601.5k)(497.6k)(508.0k)(396.5k)

EBIT margin, %

(743%)(741%)(63316%)(11848%)

Interest expense

66.5k79.3k99.0k116.8k131.8k144.5k147.0k183.2k374.1k208.3k169.7k266.5k612.0k

Pre tax profit

958.5k

Income tax expense

Net Income

(663.9k)177.4k(3.3m)(1.2m)958.5k(1.7m)(743.3k)(209.2k)(2.1m)(88.2k)(777.1k)(1.3m)(1.5m)

SpectraScience Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

236.6k223.5k127.5k3.6k

Accounts Receivable

60.0k7.1k950.0

Inventories

247.4k244.2k284.3k

Current Assets

801.1k859.0k611.2k361.8k

PP&E

15.9k316.0

Total Assets

2.3m2.2m1.9m1.4m

Accounts Payable

1.0m836.1k941.1k1.3m

Short-term debt

138.0k

Current Liabilities

4.9m6.6m8.9m10.8m

Total Debt

138.0k

Additional Paid-in Capital

37.1m39.5m38.2m34.6m

Retained Earnings

(41.4m)(45.9m)(49.5m)(54.0m)

Total Equity

(2.6m)(4.4m)

Financial Leverage

-0.9 x-0.5 x

Quarterly

USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

5.4k238.5k96.3k443.8k43.6k70.0k42.2k55.1k1.8k27.9k1.9k100.0k25.027.9k

Accounts Receivable

120.0k30.0k950.0950.0

Inventories

144.0k120.6k291.1k316.2k316.7k283.9k289.2k97.4k97.4k97.4k

Current Assets

542.9k657.5k643.3k1.0m672.0k661.3k619.4k645.7k392.7k401.8k479.0k423.0k288.8k312.8k

PP&E

48.8k32.0k9.0k7.2k5.4k2.0k1.2k

Total Assets

2.2m2.2m2.1m2.5m2.1m2.0m1.9m2.0m1.7m1.7m1.7m1.4m1.2m1.2m

Accounts Payable

1.1m1.0m839.5k977.1k786.1k850.3k944.9k792.9k1.1m1.1m1.2m1.5m1.8m1.8m

Short-term debt

115.0k115.0k138.0k138.0k113.0k113.0k

Current Liabilities

6.3m5.8m7.5m8.3m6.5m7.8m8.4m8.6m10.4m10.4m11.0m11.1m12.0m12.8m

Total Debt

115.0k115.0k138.0k138.0k113.0k113.0k

Additional Paid-in Capital

36.2m36.5m37.5m38.3m38.6m39.7m39.8m39.9m36.1m36.1m35.7m29.8m24.4m(3.5m)

Retained Earnings

(41.9m)(41.7m)(44.6m)(45.8m)(44.8m)(47.6m)(48.3m)(48.5m)(51.6m)(51.6m)(52.4m)(55.0m)(56.2m)(57.8m)

Total Equity

(4.1m)(3.6m)(5.4m)(5.8m)(4.4m)(5.8m)(6.5m)(6.6m)(8.8m)

Debt to Assets Ratio

0.1 x

Financial Leverage

-0.5 x-0.6 x-0.4 x-0.4 x-0.5 x-0.3 x-0.3 x-0.3 x-0.2 x

SpectraScience Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(2.7m)(4.5m)(3.6m)(4.5m)

Depreciation and Amortization

239.3k184.0k165.8k161.3k

Accounts Receivable

18.6k60.0k(7.1k)6.1k

Inventories

(45.4k)(36.2k)21.7k(25.1k)

Accounts Payable

138.7k(172.9k)105.0k377.6k

Cash From Operating Activities

(1.6m)(2.4m)(1.9m)(1.5m)

Cash From Investing Activities

(4.2k)(6.3k)

Cash From Financing Activities

1.8m2.4m1.8m1.4m

Interest Paid

12.2k18.0k

Quarterly

USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(3.3m)(3.1m)(3.3m)(4.4m)(3.5m)(1.7m)(2.5m)(2.7m)(2.1m)(88.2k)(2.9m)(2.3m)(3.8m)

Depreciation and Amortization

119.5k179.3k54.6k97.7k140.8k82.9k124.3k40.6k121.0k79.7k119.5k

Accounts Receivable

(124.3k)(34.3k)60.0k60.0k60.0k7.1k950.06.1k950.0950.0

Inventories

58.1k81.4k(43.7k)(68.7k)(69.2k)283.9k(5.6k)(20.2k)(31.6k)(45.7k)97.4k(6.8k)(6.8k)

Accounts Payable

195.0k144.2k(169.5k)(31.9k)(222.9k)850.3k108.8k(43.2k)127.7k1.1m244.1k1.5m454.8k713.3k

Cash From Operating Activities

(777.4k)(1.1m)(605.5k)(1.2m)(1.9m)(929.8k)(1.6m)(407.0k)(1.2m)(389.4k)(486.0k)

Cash From Investing Activities

(1.6k)(6.3k)(6.3k)(6.3k)

Cash From Financing Activities

692.6k1.2m471.5k1.4m1.7m748.5k1.4m281.3k1.1m385.8k510.3k

Interest Paid

5.5k8.0k1.0k1.0k

SpectraScience Ratios

USDY, 2017

EV/EBIT

-0.4 x

EV/CFO

-0.3 x

Debt/Assets

0.1 x